DATA GRAPHICS | Data Byte
FDA approved five NMEs in April
Day One, X4 and ImmunityBio each received their first drug approvals
May 2, 2024 10:42 PM UTC
Three of the five new medicines FDA approved in April marked the transition of their manufacturers to commercial-stage companies.
Day One Biopharmaceuticals Inc. (NASDAQ:DAWN) and X4 Pharmaceuticals Inc. (NASDAQ:XFOR) each gained their first-ever approval for a pediatric indication...